1. Rinkel GJ, Djibuti M, Algra A, van Gijn J. Prevalence and risk of rupture of intracranial aneurysms: a systematic review. Stroke. 1998;29(1):251-256.
2. Thompson BG, Brown RD Jr, Amin-Hanjani S, et al. Guide- lines for the management of patients with unruptured intra- cranial aneurysms: a guideline for healthcare professionals from the American Heart Association/American Stroke Asso- ciation. Stroke. 2015;46(8):2368-2400.
3. Lasheras JC. The biomechanics of arterial aneurysms. Annu Rev Fluid Mech. 2007;39:293-319.
4. Meng H, Wang Z, Hoi Y, et al. Complex hemodynamics at the apex of an arterial bifurcation induces vascular remodeling resem- bling cerebral aneurysm initiation. Stroke. 2007;38(6):1924-1931.
5. Chalouhi N, Ali MS, Jabbour PM, et al. Biology of intracranial aneurysms: role of in?ammation. J Cereb Blood Flow Metab. 2012;32(9):1659-1676.
6. Starke RM, Chalouhi N, Ali MS, et al. The role of oxidative stress in cerebral aneurysm formation and rupture. Curr Neu- rovasc Res. 2013;10(3):247-255.
7. Chalouhi N, Ali MS, Starke RM, et al. Cigarette smoke and in?ammation: role in cerebral aneurysm formation and rupture. Mediators In?amm. 2012;2012:271582.
8. Aoki T, Kataoka H, Morimoto M, Nozaki K, Hashimoto N. Macrophage-derived matrix metalloproteinase-2 and -9 pro- mote the progression of cerebral aneurysms in rats. Stroke. 2007;38(1):162-169.
9. Hasan DM, Mahaney KB, Brown RD Jr, et al. Aspirin as a promising agent for decreasing incidence of cerebral aneu- rysm rupture. Stroke. 2011;42(11):3156-3162.
10. Frenzel T, Lee CZ, Kim H, et al. Feasibility of minocycline and doxycycline use as potential vasculostatic therapy for brain vascular malformations: pilot study of adverse events and tolerance. Cerebrovasc Dis. 2008;25(1-2):157-163.
11. Makino H, Tada Y, Wada K, et al. Pharmacological stabilization of intracranial aneurysms in mice: a feasibility study. Stroke. 2012;43(9):2450-2456.
12. Hasan D, Chalouhi N, Jabbour P, Hashimoto T. Macrophage imbalance (M1 vs. M2) and upregulation of mast cells in wall of ruptured human cerebral aneurysms: preliminary re- sults. J Neuroin?ammation. 2012;9:222.
13. Frosen J, Piippo A, Paetau A, et al. Remodeling of saccular ce- rebral artery aneurysm wall is associated with rupture: histo- logical analysis of 24 unruptured and 42 ruptured cases. Stroke. 2004;35(10):2287-2293.Alg VS, Sofat R, Houlden H, Werring DJ. Genetic risk factors for intracranial aneurysms: a meta-analysis in more than 116, 000 individuals. Neurology. 2013;80(23):2154-2165.
14. Weir B. Unruptured intracranial aneurysms: a review. J Neurosurg. 2002;96(1):3-42.
15. Vernooij MW, Ikram MA, Tanghe HL, et al. Incidental ?ndings on brain MRI in the general population. N Engl J Med. 2007; 357(18):1821-1828.
16. Vlak MH, Algra A, Brandenburg R, Rinkel GJ. Prevalence of unruptured intracranial aneurysms, with emphasis on sex,age, comorbidity, country, and time period: a systematic re- view and meta-nalysis. Lancet Neurol. 2011;10(7):626-636.
17. Connolly ES, Solomon RA. Management of unruptured aneu- rysms. In: Le Roux PD, Winn HR, Newell DW, eds. Manage- ment of Cerebral Aneurysms. Philadelphia: WB Saunders; 2004: 271-285.
18. Juvela S, Poussa K, Porras M. Factors affecting formation and growth of intracranial aneurysms: a long-term follow-up study. Stroke. 2001;32(2):485-491.
19. Sprengers ME, van Rooij WJ, Sluzewski M, et al. MR angiog- raphy follow-up 5 years after coiling: frequency of new aneu- rysms and enlargement of untreated aneurysms. AJNR Am J Neuroradiol. 2009;30(2):303-307.
20. Wermer MJ, van der Schaaf IC, Velthuis BK, Algra A, Buskens E, Rinkel GJ; ASTRA Study Group. Follow-up screening after subarachnoid haemorrhage: frequency and de- terminants of new aneurysms and enlargement of existing an- eurysms. Brain. 2005;128(pt 10):2421-2429.
21. Ferns SP, Sprengers ME, van Rooij WJ, et al. De novo aneu- rysm formation and growth of untreated aneurysms: a 5- year MRA follow-up in a large cohort of patients with coiled aneurysms and review of the literature. Stroke. 2011;42(2): 313-318.
22. Schievink WI. Intracranial aneurysms [erratum appears in N Engl J Med. 1997;336(17):1267]. N Engl J Med. 1997;336(1): 28-40.
23. Nieuwkamp DJ, Setz LE, Algra A, Linn FH, de Rooij NK, Rinkel GJ. Changes in case fatality of aneurysmal subarachnoid haemorrhage over time, according to age, sex, and region: a meta-analysis. Lancet Neurol. 2009;8(7):635-642.
24. Mackey J, Brown RD Jr, Moomaw CJ, et al. Familial intracranial aneurysms: is anatomic vulnerability heritable? Stroke. 2013; 44(1):38-42.
25. St Jean P, Hart B, Webster M, et al. Alpha-1-antitrypsin de?ciency in aneurysmal disease. Hum Hered. 1996;46(2):92-97.
26. Ronkainen A, Hernesniemi J, Puranen M, et al. Familial intra- cranial aneurysms. Lancet. 1997;349(9049):380-384.
27. Broderick JP, Brown RD Jr, Sauerbeck L, et al. Greater rupture risk for familial as compared to sporadic unruptured intracra- nial aneurysms. Stroke. 2009;40(6):1952-1957.
28. Brown RD Jr, Huston J, Hornung R, et al. Screening for brain aneurysm in the Familial Intracranial Aneurysm study: fre- quency and predictors of lesion detection. J Neurosurg. 2008;108(6):1132-1138.
29. Lindgren AE, Kurki MI, Riihinen A, et al. Hypertension predis- poses to the formation of saccular intracranial aneurysms in 467 unruptured and 1053 ruptured patients in Eastern Finland. Ann Med. 2014;46(3):169-176.
30. Etminan N, Chang HS, Hackenberg K, et al. Worldwide inci- dence of aneurysmal subarachnoid hemorrhage according to region, time period, blood pressure, and smoking prevalence in the population: a systematic review and meta-analysis. JAMA Neurol. 2019;76(5):588-597.
31. Vlak MH, Rinkel GJ, Greebe P, Algra A. Independent risk fac- tors for intracranial aneurysms and their joint effect: a case- control study. Stroke. 2013;44(4):984-987.
32. Aoki T, Kataoka H, Ishibashi R, et al. Pitavastatin suppresses formation and progression of cerebral aneurysms through in- hibition of the nuclear factor kB pathway. Neurosurgery. 2009; 64(2):357-365; discussion 365-366.
33. Marbacher S, Schlappi JA, Fung C, Husler J, Beck J, Raabe A. Do statins reduce the risk of aneurysm development? A case-control study. J Neurosurg. 2012;116(3):638-642.
34. Vlak MH, Rinkel GJ, Greebe P, Greving JP, Algra A. Lifetime risks for aneurysmal subarachnoid haemorrhage: multivariable risk strati?cation. J Neurol Neurosurg Psychiatry. 2013;84(6): 619-623.
35. Vlak MH, Rinkel GJ, Greebe P, van der Bom JG, Algra A. Trigger factors and their attributable risk for rupture of intracranial aneurysms: a case-crossover study. Stroke. 2011; 42(7):1878-1882.
36. Anderson C, Ni Mhurchu C, Scott D, Bennett D, Jamrozik K, Hankey G; Australasian Cooperative Research on Subarach- noid Hemorrhage Study Group. Triggers of subarachnoid hemorrhage: role of physical exertion, smoking, and alcohol in the Australasian Cooperative Research on Subarachnoid Hemorrhage Study (ACROSS). Stroke. 2003;34(7):1771- 1776.
37. Gagliardi D, Faravelli I, Villa L, et al. Bilateral cavernous carotid aneurysms: atypical presentation of a rare cause of mass effect. A case report and a review of the literature. Front Neurol. 2018;9:619.
38. Raps EC, Rogers JD, Galetta SL, et al. The clinical spectrum of unruptured intracranial aneurysms. Arch Neurol. 1993;50(3): 265-268.
39. Chappell ET, Moure FC, Good MC. Comparison of computed tomographic angiography with digital subtraction angiography in the diagnosis of cerebral aneurysms: a meta-analysis. Neuro- surgery. 2003;52(3):624-631; discussion 630-631.
40. White PM, Wardlaw JM, Easton V. Can noninvasive imaging accurately depict intracranial aneurysms? A systematic review. Radiology. 2000;217(2):361-370.
41. Menke J, Larsen J, Kallenberg K. Diagnosing cerebral aneurysms by computed tomographic angiography: meta-analysis. Ann Neurol. 2011;69(4):646-654.
42. Hirai T, Korogi Y, Ono K, et al. Preoperative evaluation of intracranial aneurysms: usefulness of intraarterial 3D CT angi- ography and conventional angiography with a combined uni- tdinitial experience. Radiology. 2001;220(2):499-505.
43. Sailer AM, Wagemans BA, Nelemans PJ, de Graaf R, van Zwam WH. Diagnosing intracranial aneurysms with MR angi- ography: systematic review and meta-analysis. Stroke. 2014; 45(1):119-126.
44. White PM, Teasdale EM, Wardlaw JM, Easton V. Intracranial aneurysms: CT angiography and MR angiography for detec- tion prospective blinded comparison in a large patient cohort. Radiology. 2001;219(3):739-749.
45. Weng HH, Jao SY, Yang CY, Tsai YH. Meta-analysis on diag- nostic accuracy of MR angiography in the follow-up of residual intracranial aneurysms treated with Guglielmi detachable coils. Interv Neuroradiol. 2008;14(suppl 2):53-63.
46. Yoon DY, Lim KJ, Choi CS, Cho BM, Oh SM, Chang SK. Detec- tion and characterization of intracranial aneurysms with 16- channel multidetector row CT angiography: a prospective com- parison of volume-rendered images and digital subtraction angi- ography. AJNR Am J Neuroradiol. 2007;28(1):60-67.
47. Teksam M, McKinney A, Casey S, Asis M, Kieffer S, Truwit CL. Multi-section CT angiography for detection of cerebral aneu- rysms. AJNR Am J Neuroradiol. 2004;25(9):1485-1492.
48. Dammert S, Krings T, Moller-Hartmann W, et al. Detection of intracranial aneurysms with multislice CT: comparison with conventional angiography. Neuroradiology. 2004;46(6): 427-434.
49. McKinney AM, Palmer CS, Truwit CL, Karagulle A, Teksam M. Detection of aneurysms by 64-section multidetector CT angi- ography in patients acutely suspected of having an intracranial aneurysm and comparison with digital subtraction and 3D rotational angiography. AJNR Am J Neuroradiol. 2008;29(3): 594-602.
50. Kucukay F, Okten RS, Tekiner A, et al. Three-dimensional vol- ume rendering digital subtraction angiography in comparison with two-dimensional digital subtraction angiography and rotational angiography for detecting aneurysms and their morphological properties in patients with subarachnoid hem- orrhage. Eur J Radiol. 2012;81(10):2794-2800.
51. van Rooij WJ, Sprengers ME, de Gast AN, Peluso JP, Sluzewski M. 3D rotational angiography: the new gold stan- dard in the detection of additional intracranial aneurysms. AJNR Am J Neuroradiol. 2008;29(5):976-979.
52. Wong SC, Nawawi O, Ramli N, Abd Kadir KA. Bene?ts of 3D rotational DSA compared with 2D DSA in the evaluation of intracranial aneurysm. Acad Radiol. 2012;19(6):701-707.
53. Friedman JA, Piepgras DG, Pichelmann MA, Hansen KK, Brown RD Jr, Wiebers DO. Small cerebral aneurysms pre- senting with symptoms other than rupture. Neurology. 2001; 57(7):1212-1216.
54. Rinkel GJ. Intracranial aneurysm screening: indications and advice for practice. Lancet Neurol. 2005;4(2):122-128.
55. Backes D, Rinkel GJ, Laban KG, Algra A, Vergouwen MD. Pa- tient- and aneurysm-speci?c risk factors for intracranial aneu- rysm growth: a systematic review and meta-analysis. Stroke. 2016;47(4):951-957.
56. Burns JD, Huston J 3rd, Layton KF, Piepgras DG, Brown RD Jr. Intracranial aneurysm enlargement on serial magnetic reso- nance angiography: frequency and risk factors. Stroke. 2009; 40(2):406-411.
57. Etminan N, Buchholz BA, Dreier R, et al. Cerebral aneurysms: formation, progression, and developmental chronology. Transl Stroke Res. 2014;5(2):167-173.
58. Kof?jberg H, Buskens E, Algra A, Wermer MJ, Rinkel GJ. Growth rates of intracranial aneurysms: exploring constancy. J Neurosurg. 2008;109(2):176-185.
59. Matsubara S, Hadeishi H, Suzuki A, Yasui N, Nishimura H. Inci- dence and risk factors for the growth of unruptured cerebral aneurysms: observation using serial computerized tomography angiography. J Neurosurg. 2004;101(6):908-914.
60. Chien A, Liang F, Sayre J, Salamon N, Villablanca P, Vinuela F. Enlargement of small, asymptomatic, unruptured intracranial aneurysms in patients with no history of subarachnoid hemor- rhage: the different factors related to the growth of single and multiple aneurysms. J Neurosurg. 2013;119(1):190-197.
61. Wiebers DO, Torres VE. Screening for unruptured intracra- nial aneurysms in autosomal dominant polycystic kidney dis- ease. N Engl J Med. 1992;327(1):953-955.
62. Wiebers DO, Whisnant JP, Huston J 3rd, et al. Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment. Lancet. 2003; 362(9378):103-110.
63. UCAS Japan Investigators, Morita A, Kirino T, Hashi K, et al. The natural course of unruptured cerebral aneurysms in a Jap- anese cohort. N Engl J Med. 2012;366(26):2474-2482.
64. Sonobe M, Yamazaki T, Yonekura M, Kikuchi H. Small unrup- tured intracranial aneurysm veri?cation study: SUAVe study. Japan. Stroke.. 2010;41(9):1969-1977.
65. Brinjikji W, Zhu YQ, Lanzino G, et al. Risk factors for growth of intracranial aneurysms: a systematic review and meta-anal- ysis. AJNR Am J Neuroradiol. 2016;37(4):615-620.
66. Malhotra A, Wu X, Forman HP, et al. Growth and rupture risk of small unruptured intracranial aneurysms: a systematic re- view. Ann Intern Med. 2017;167(1):26-33.
67. Wermer MJ, van der Schaaf IC, Algra A, Rinkel GJ. Risk of rupture of unruptured intracranial aneurysms in relation to pa- tient and aneurysm characteristics: an updated meta-analysis. Stroke. 2007;38(4):1404-1410.
68. Kashiwazaki D, Kuroda S; Sapporo SAH Study Group. Size ra- tio can highly predict rupture risk in intracranial small (<5 mm) aneurysms. Stroke. 2013;44(8):2169-2173.
69. Greving JP, Wermer MJ, Brown RD Jr, et al. Development of the PHASES score for prediction of risk of rupture of intracra- nial aneurysms: a pooled analysis of six prospective cohort studies. Lancet Neurol. 2014;13(1):59-66.
70. Bijlenga P, Gondar R, Schilling S, et al. PHASES score for the management of intracranial aneurysm: a cross-sectional popu- lation-based retrospective study. Stroke. 2017;48(8):2105- 2112.
71. Schmidt M, Johansen MB, Lash TL, Christiansen CF, Christensen S, Sørensen HT. Antiplatelet drugs and risk of subarachnoid hemorrhage: a population-based case-control study. J Thromb Haemost. 2010;8(7):1468-1474.
72. Toussaint LG 3rd, Friedman JA, Wijdicks EF, et al. In?uence of aspirin on outcome following aneurysmal subarachnoid hem- orrhage. J Neurosurg. 2004;101(6):921-925.
73. Brown RD Jr, Broderick JP. Unruptured intracranial aneurysms: epidemiology, natural history, management options, and famil- ial screening. Lancet Neurol. 2014;13(4):393-404.
74. Rinkel GJ, Prins NE, Algra A. Outcome of aneurysmal sub- arachnoid hemorrhage in patients on anticoagulant treatment. Stroke. 1997;28(1):6-9.
75. Tarlov N, Norbash AM, Nguyen TN. The safety of anticoagu- lation in patients with intracranial aneurysms. J Neurointerv Surg. 2013;5(5):405-409.
76. Vergouwen MD, Rinkel GJ, Algra A, et al. Prospective Ran- domized Open-label Trial to evaluate risk faCTor manage- ment in patients with Unruptured intracranial aneurysms: study protocol. Int J Stroke. 2018;13(9):992-998.
77. Etminan N, Brown RD Jr, Beseoglu K, et al. The unruptured intracranial aneurysm treatment score: a multidisciplinary consensus. Neurology. 2015;85(10):881-889.
78. Williams LN, Brown RD Jr. Management of unruptured intra- cranial aneurysms [erratum appears in Neurol Clin Pract. 2014; 4(2):98]. Neurol Clin Pract. 2013;3(2):99-108.
79. Bederson JB, Awad IA, Wiebers DO, et al. Recommendations for the management of patients with unruptured intracranial aneurysms: a statement for healthcare professionals from the Stroke Council of the American Heart Association. Circu- lation. 2000;102(18):2300-2308.
80. Xu HW, Yu SQ, Mei CL, Li MH. Screening for intracranial aneurysm in 355 patients with autosomal-dominant polycystic kidney disease. Stroke. 2011;42(1):204-206.
81. Connolly HM, Huston J 3rd, Brown RD Jr, Warnes CA, Ammash NM, Tajik AJ. Intracranial aneurysms in patients with coarctation of the aorta: a prospective magnetic reso- nance angiographic study of 100 patients. Mayo Clin Proc. 2003;78(12):1491-1499.
82. Magnetic Resonance Angiography in Relatives of Patients with Subarachnoid Hemorrhage Study Group. Risks and bene?ts of screening for intracranial aneurysms in ?rst-degree relatives of patients with sporadic subarachnoid hemorrhage. N Engl J Med. 1999;341(18):1344-1350.
83. Wiebers DO, Piepgras DG, Meyer FB, et al. Pathogenesis, nat- ural history, and treatment of unruptured intracranial aneu- rysms. Mayo Clin Proc. 2004;79(12):1572-1583.
84. Malhotra A, Wu X, Forman HP, Matouk CC, Gandhi D, Sanelli P. Management of Tiny unruptured intracranial aneu- rysms: a comparative effectiveness analysis. JAMA Neurol. 2018;75(1):27-34.
85. Backes D, Rinkel GJ, van der Schaaf IC, et al. Recovery to pre- interventional functioning, return-to-work, and life satisfaction after treatment of unruptured aneurysms. Stroke. 2015;46(6): 1607-1612.
86. Yamaki VN, Brinjikji W, Murad MH, Lanzino G. Endovascular treatment of very small intracranial aneurysms: meta-analysis. AJNR Am J Neuroradiol. 2016;37(5):862-867.
87. Algra AM, Lindgren A, Vergouwen MDI, et al. Procedural clin- ical complications, case-fatality risks, and risk factors in endo- vascular and neurosurgical treatment of unruptured intracranial aneurysms: a systematic review and meta-analysis. JAMA Neurol. 2019;76(3):282-293.
88. David CA, Vishteh AG, Spetzler RF, Lemole M, Lawton MT, Partovi S. Late angiographic follow-up review of surgically treated aneurysms. J Neurosurg. 1999;91(3):396-401.
89. Ajiboye N, Chalouhi N, Starke RM, Zanaty M, Bell R. Unrup- tured cerebral aneurysms: evaluation and management. Scien- ti?cWorldJournal. 2015;2015:954954.
90. King JT Jr, Berlin JA, Flamm ES. Morbidity and mortality from elective surgery for asymptomatic, unruptured, intra- cranial aneurysms: a meta-analysis. J Neurosurg. 1994;81(6): 837-842.
91. Raaymakers TW, Rinkel GJ, Limburg M, Algra A. Mortality and morbidity of surgery for unruptured intracranial aneurysms: a meta-analysis. Stroke. 1998;29(8):1531-1538.
92. Kotowski M, Naggara O, Darsaut TE, et al. Safety and occlu- sion rates of surgical treatment of unruptured intracranial an- eurysms: a systematic review and meta-analysis of the literature from 1990 to 2011. J Neurol Neurosurg Psychiatry. 2013;84(1):42-48.
93. Ohue S, Oka Y, Kumon Y, et al. Importance of neuropsycho- logical evaluation after surgery in patients with unruptured ce- rebral aneurysms. Surg Neurol. 2003;59(4):269-275; discussion 275-276.
94. Pereira-Filho AA, Pereira AG, Faria MB, Lima LC, Portuguez MW, Kraemer JL. Microsurgical clipping in forty pa- tients with unruptured anterior cerebral circulation aneurysms: an investigation into cognitive outcome. Arq Neuropsiquiatr. 2010;68(5):770-774.
95. Alshekhlee A, Mehta S, Edgell RC, et al. Hospital mortality and complications of electively clipped or coiled unruptured intra- cranial aneurysm. Stroke. 2010;41(7):1471-1476.
96. McDonald JS, McDonald RJ, Fan J, Kallmes DF, Lanzino G, Cloft HJ. Comparative effectiveness of unruptured cerebral aneurysm therapies: propensity score analysis of clipping versus coiling. Stroke. 2013;44(4):988-994.
97. Hoh BL, Nathoo S, Chi YY, Mocco J, Barker FG 2nd. Incidence of seizures or epilepsy after clipping or coiling of ruptured and unruptured cerebral aneurysms in the nationwide inpatient sample database: 2002-2007. Neurosurgery. 2011;69(3):644- 650; discussion 650.
98. Berman MF, Solomon RA, Mayer SA, Johnston SC, Yung PP. Impact of hospital-related factors on outcome after treatment of cerebral aneurysms. Stroke. 2003;34(9):2200-2207.
99. Chyatte D, Porter?eld R. Functional outcome after repair of unruptured intracranial aneurysms. J Neurosurg. 2001;94(3): 417-421.
100. Barker FG 2nd, Amin-Hanjani S, Butler WE, Ogilvy CS, Carter BS. In-hospital mortality and morbidity after surgical treatment of unruptured intracranial aneurysms in the United States, 1996-2000: the effect of hospital and surgeon volume. Neurosurgery. 2003;52(5):995-1007; discussion 1007-1009.
101. Brinjikji W, Rabinstein AA, Nasr DM, Lanzino G, Kallmes DF, Cloft HJ. Better outcomes with treatment by coiling relative to clipping of unruptured intracranial aneurysms in the United States, 2001-2008. AJNR Am J Neuroradiol. 2011;32(6):1071-1075.
102. Molyneux A, Kerr R, Stratton I, et al. International Subarach- noid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracra- nial aneurysms: a randomised trial. Lancet. 2002;360(9342): 1267-1274.
103. Naggara ON, Lecler A, Oppenheim C, Meder JF, Raymond J. Endovascular treatment of intracranial unruptured aneurysms: a systematic review of the literature on safety with emphasis on subgroup analyses. Radiology. 2012;263(3):828-835.
104. Kan P, Siddiqui AH, Veznedaroglu E, et al. Early postmarket re- sults after treatment of intracranial aneurysms with the pipe- line embolization device: a U.S. multicenter experience. Neurosurgery. 2012;71(6):1080-1087; discussion 1087-1088.
105. Behme D, Berlis A, Weber W. Woven EndoBridge intrasacc- ular ?ow disrupter for the treatment of ruptured and unrup- tured wide-neck cerebral aneurysms: report of 55 cases. AJNR Am J Neuroradiol. 2015;36(8):1501-1506.
106. Pierot L, Costalat V, Moret J, et al. Safety and ef?cacy of aneu- rysm treatment with WEB: results of the WEBCAST study. J Neurosurg. 2016;124(5):1250-1256.
107. Pierot L, Klisch J, Liebig T, et al. WEB-DL endovascular treat- ment of wide-neck bifurcation aneurysms: long-term results in a European series [erratum appears in AJNR Am J Neuroradiol. 2016;37(2):E19]. AJNR Am J Neuroradiol. 2015;36(12):2314- 2319.
108. Pierot L, Moret J, Barreau X, et al. Safety and ef?cacy of aneu- rysm treatment with WEB in the cumulative population of three prospective, multicenter series. J Neurointerv Surg. 2018;10(6):553-559.
109. Pierot L, Moret J, Turjman F, et al. WEB treatment of intracra- nial aneurysms: clinical and anatomic results in the French ob- servatory. AJNR Am J Neuroradiol. 2016;37(4):655-659.
110. Pierot L, Spelle L, Molyneux A, Byrne J; Webcast and French Observatory Imvestigators. Clinical and anatomical follow-up in patients with aneurysms treated with the WEB device: 1- year follow-up report in the cumulated population of 2 pro- spective, multicenter series (WEBCAST and French Observa- tory). Neurosurgery. 2016;78(1):133-141.
111. Arthur AS, Molyneux A, Coon AL, et al. The safety and effec- tiveness of the Woven EndoBridge (WEB) system for the treatment of wide-necked bifurcation aneurysms: ?nal 12- month results of the pivotal WEB Intrasaccular Therapy (WEB-IT) study. J Neurointerv Surg. 2019;11(9):924-930.
112. Pierot L, Liebig T, Sychra V, et al. Intrasaccular ?ow-disruption treatment of intracranial aneurysms: preliminary results of a multicenter clinical study. AJNR Am J Neuroradiol. 2012;33(7): 1232-1238.
113. Wanke I, Doer?er A, Dietrich U, et al. Endovascular treatment of unruptured intracranial aneurysms. AJNR Am J Neuroradiol. 2002;23(5):756-761.
114. Soeda A, Sakai N, Sakai H, et al. Thromboembolic events associated with Guglielmi detachable coil embolization of asymptomatic cerebral aneurysms: evaluation of 66 consecu- tive cases with use of diffusion-weighted MR imaging. AJNR Am J Neuroradiol. 2003;24(1):127-132.
Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.